4 Largecap One-Year Winners With High Profit CAGR Stocks to Watch for Future Multibagger Potential: Shriram Finance, Torrent Pharma, BSE and BHEL

One-year winners with high profit CAGR stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Shriram Finance, Torrent Pharma, BSE and BHEL meet that test, with market caps from Rs 1.52 lakh crore to Rs 2.19 lakh crore and Shriram Finance offering the lowest PE of the group at 19.38. Each of these companies has a one-year share price return of at least 25 per cent and a four year profit CAGR of at least 15 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.

This list covers companies with a one-year share price return of at least 25 per cent and a four year profit CAGR of at least 15 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening one-year winners with high profit CAGR stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 3 November 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are One-Year Winners With High Profit CAGR Stocks and Why Do They Attract Multibagger Interest?

One-year winners with high profit CAGR stocks are shares of large companies that have gained at least a quarter in value over the last year and whose profit has compounded at fifteen per cent or more a year from FY22 to FY26. The four here cover vehicle finance, pharmaceuticals, stock exchange services and heavy electrical equipment.

A strong one year run shows that the market has noticed the business, and four years of compounding profit shows that the rise rests on a steady earnings record and not on a single good year. Within one-year winners with high profit CAGR stocks, the four companies show rising profit. For one-year winners with high profit CAGR stocks, both FY26 and the latest quarter showed growth. Whichever way you read one-year winners with high profit CAGR stocks, the common thread is rising profit backed by complete financial data. Investors researching one-year winners with high profit CAGR stocks get a fuller picture by reading growth and valuation together. The table below lines up one-year winners with high profit CAGR stocks on size, growth and valuation, using complete FY26 and latest quarter numbers. Past performance does not guarantee future returns, so use one-year winners with high profit CAGR stocks as a starting point for your own research.

One-Year Winners With High Profit CAGR Stocks at a Glance: Price, Market Cap, PE, ROE and Price to Book

Prices are closing prices as of 3 November 2026. Shriram Finance has the lowest PE of the group at 19.38, while BSE posts the highest return on equity at 37.42%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Price to Book	52-Week Range (Rs)
Shriram Finance	884.80	2,19,317	19.38	17.68	15.21%	2.08	662.25 to 1,153.70
Torrent Pharmaceuticals	4,650	1,76,513	81.87	36.42	25.49%	20.99	3,480.60 to 5,250.00
BSE Ltd	3,665.70	1,56,983	55.63	42.42	37.42%	23.52	2,326.10 to 4,446.80
Bharat Heavy Electricals	400	1,51,782	52.70	45.89	10.76%	5.68	229.54 to 464.00

Shriram Finance: 38.64% Profit CAGR Since FY22

Shriram Finance is a major NBFC focused on commercial vehicle, small business and personal loans. It reported FY26 total income of Rs 48,192.65 crore, up 15.13% year on year, and net profit of Rs 10,004.20 crore, up 6.16%. Net profit has compounded at 38.64% a year since FY22, while total income has grown 25.75% a year.

In the June 2026 quarter, total income rose 16.26% to Rs 13,418.74 crore and net profit grew 59.95% to Rs 3,447.26 crore. The share price has gained 239.61% over five years and 40.91% over the past year. Domestic institutions raised their holding from 18.66% in September 2025 to 19.90% in June 2026. The stock trades at a PE of 19.38 against an industry PE of 17.68, with a return on equity of 15.21%.

Torrent Pharma: 28.79% Profit CAGR Since FY22

Torrent Pharmaceuticals makes branded medicines for chronic therapies such as cardiac, gastro-intestinal and central nervous system care in India and overseas. It reported FY26 revenue of Rs 13,886.15 crore, up 20.34% year on year, and net profit of Rs 2,138.18 crore, up 11.87%. Net profit has compounded at 28.79% a year since FY22, while revenue has grown 12.38% a year. Operating margin was 22.70% in FY26.

The stock trades at a PE of 81.87 against an industry PE of 36.42, with a return on equity of 25.49%. In the June 2026 quarter, revenue rose 56.29% to Rs 4,909 crore and net profit grew 3.28% to Rs 566 crore. The share price has gained 194.63% over five years and 29.72% over the past year. Domestic institutions raised their holding from 9.28% in September 2025 to 12.87% in July 2026.

BSE: 78.30% Profit CAGR Since FY22

BSE Ltd operates one of India's two major stock exchanges and earns from trading, listing, data and clearing services. It reported FY26 revenue of Rs 5,148.10 crore, up 59.07% year on year, and net profit of Rs 2,475.30 crore, up 87.94%. Net profit has compounded at 78.30% a year since FY22, while revenue has grown 56.26% a year. Operating margin was 68.39% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.

In the June 2026 quarter, revenue rose 63.41% to Rs 1,706.72 crore and net profit grew 62.15% to Rs 872.66 crore. The share price has gained 2101.66% over five years and 37.49% over the past year. Domestic institutions raised their holding from 13.51% in June 2025 to 24.15% in June 2026. The stock trades at a PE of 55.63 against an industry PE of 42.42, with a return on equity of 37.42%.

BHEL: 37.73% Profit CAGR Since FY22

Bharat Heavy Electricals is a government-owned maker of power generation, transmission, industrial and transportation equipment. It reported FY26 revenue of Rs 34,589.83 crore, up 20.08% year on year, and net profit of Rs 1,600.26 crore, up 199.73%. Net profit has compounded at 37.73% a year since FY22, while revenue has grown 12.54% a year. Operating margin was 10.18% in FY26. The debt-to-equity ratio is 0.23.

The stock trades at a PE of 52.70 against an industry PE of 45.89. In the September 2026 quarter, revenue rose 24.28% to Rs 9,553.01 crore and net profit grew 118.98% to Rs 820.94 crore. The share price has gained 488.34% over five years and 86.13% over the past year. Domestic institutions raised their holding from 18.62% in September 2025 to 21.88% in September 2026.

One-Year Winners With High Profit CAGR Stocks: Financial Comparison on Growth and Margins

The table compares scale and growth across these one-year winners with high profit CAGR stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Total Income (Rs Cr)	Net Profit (Rs Cr)	Income Growth (YoY)	4-Year Income CAGR	4-Year Net Profit CAGR
Shriram Finance	48,192.65	10,004.20	15.13%	25.75%	38.64%
Torrent Pharma	13,886.15	2,138.18	20.34%	12.38%	28.79%
BSE	5,148.10	2,475.30	59.07%	56.26%	78.30%
BHEL	34,589.83	1,600.26	20.08%	12.54%	37.73%

Check the Univest Screener for live data on these one-year winners with high profit CAGR stocks

Institutional Holding in Shriram Finance, Torrent Pharma, BSE and BHEL

Institutional holding shows who is backing these one-year winners with high profit CAGR stocks alongside the promoter. The table uses the latest reported quarter for each. Shriram Finance has the deepest institutional backing, with FII and DII together holding 74.67% as of June 2026. Domestic institutions increased their holding over the past year in Shriram Finance (from 18.66% to 19.90%), Torrent Pharma (from 9.28% to 12.87%), BSE (from 13.51% to 24.15%) and BHEL (from 18.62% to 21.88%).

Stock	Promoter	FII	DII	Public	Quarter
Shriram Finance	20.30%	54.77%	19.90%	5.04%	June 2026
Torrent Pharma	60.78%	17.97%	12.87%	8.38%	July 2026
BSE	Nil	21.32%	24.15%	54.53%	June 2026
BHEL	58.17%	9.94%	21.88%	10.02%	September 2026

Risks to Weigh in One-Year Winners With High Profit CAGR Stocks

Being careful with one-year winners with high profit CAGR stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Past growth may not repeat.
• Share prices can move sharply in either direction.
• Valuation: Torrent Pharma trades at a PE of 81.87 against an industry PE of 36.42, so earnings need to keep growing to support the price.
• Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between One-Year Winners With High Profit CAGR Stocks

Picking from one-year winners with high profit CAGR stocks comes down to four checks, applied in order.

1. Check asset quality and net interest margin first, then return on equity and price to book. Debt-to-equity does not apply to lenders.
2. Compare each PE with the industry PE (17.68 to 45.89) and ask whether the growth rate justifies any gap.
3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track Shriram Finance, Torrent Pharma, BSE and BHEL live prices.

Conclusion

Among one-year winners with high profit CAGR stocks, Shriram Finance stands out for the lowest PE of the group at 19.38, Torrent Pharma for 20.34% revenue growth in FY26, BSE for the highest return on equity at 37.42% and BHEL for the strongest latest-quarter profit growth at 118.98%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing one-year winners with high profit CAGR stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on One-Year Winners With High Profit CAGR Stocks to Watch

Which are the best one-year winners with high profit CAGR stocks to watch for multibagger potential?

Ans. Shriram Finance, Torrent Pharma, BSE and BHEL are the 4 names this list highlights, with market caps of Rs 2,19,317 crore, Rs 1,76,513 crore, Rs 1,56,983 crore and Rs 1,51,782 crore respectively. Shriram Finance is notable for the lowest PE of the group at 19.38. Torrent Pharma stands out for 20.34% revenue growth in FY26. BSE offers the highest return on equity at 37.42%. BHEL brings the strongest latest-quarter profit growth at 118.98%. These are watchlist names for one-year winners with high profit CAGR stocks, not recommendations, so match each one to your own risk profile and time horizon.

Is BSE a good stock for long-term investors?

Ans. BSE has a return on equity of 37.42%, a PE of 55.63 against an industry PE of 42.42 and a market cap of Rs 1,56,983 crore. Net profit has compounded at 78.30% a year since FY22, and FY26 revenue rose 59.07% while June 2026 quarter net profit grew 62.15%. Long-term returns in one-year winners with high profit CAGR stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can Shriram Finance become a multibagger from here?

Ans. Shriram Finance has already gained 239.61% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in one-year winners with high profit CAGR stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 38.64% a year since FY22, and FY26 revenue rose 15.13%. At a PE of 19.38 against an industry PE of 17.68, valuation should be checked against that growth before investing.

What is the market cap of Shriram Finance, Torrent Pharma, BSE and BHEL?

Ans. As of 3 November 2026, Shriram Finance has a market cap of Rs 2,19,317 crore, Torrent Pharma has a market cap of Rs 1,76,513 crore, BSE has a market cap of Rs 1,56,983 crore and BHEL has a market cap of Rs 1,51,782 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on one-year winners with high profit CAGR stocks.

What are the risks of investing in one-year winners with high profit CAGR stocks?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Torrent Pharma trades at a PE of 81.87 against an industry PE of 36.42, so earnings growth needs to hold up.

Why is Torrent Pharma trading at a PE of 81.87?

Ans. Torrent Pharma's PE of 81.87 compares with an industry PE of 36.42. The market is paying a premium for a return on equity of 25.49%, profit growth of 28.79% a year since FY22 and FY26 revenue growth of 20.34%, which also means the stock is more sensitive if growth slows. Investors in one-year winners with high profit CAGR stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in Shriram Finance, Torrent Pharma, BSE and BHEL?

Ans. As of the latest reported quarter, FII and DII together hold 74.67% of Shriram Finance (54.77% and 19.90%), 30.84% of Torrent Pharma (17.97% and 12.87%), 45.47% of BSE (21.32% and 24.15%) and 31.82% of BHEL (9.94% and 21.88%). Rising institutional holding is a useful signal in one-year winners with high profit CAGR stocks, though it should be read with earnings trends rather than on its own.